Department of Metabolism and Endocrinology, Graduate School of Medicine
Juntendo University, Japan
Hiroaki Satoh is serving as an Associate Professor in the Department of Department of Metabolism and Endocrinology , Juntendo University Graduate School of Medicine.
Diabetes & Metabolism
Marta Di Carlo
Group Leader, Institute of Biomedicine and Molecular Immunology
Marta Di Carlo was born in 1956. 1978 Degree cum laude in Biology. Training at aEMBL (European Molecular Biology Laboratory) in Heidelberg, Germany (1983-84), at SCLAVO Company in Siena (Italy) (1985-86), Biozentrum, Basel (Switzerland ). 1986 to present: Full position and Group Leader at IBIM (Institute of Biomedicine and Molecular Immunology) (NCR) Palermo Italy. Responsible for several National and International projects and component of ECC NoE (Network of Excellence). International referee for "Developmental Biology and Physiology" French Projects. Referee for several international ISI journals. Coauthors of more than 80 papers published on ISI Journals.
Neurodegenerative process, link between neurdegenerative and metabolic diseases, drug and gene delivery, use of simple animal models for drug discovery.
Professor, Xiangya School of Medicine
Central South University, China
Professor Zhaoqian Liu, is currently the vice deans of both Institutions of Clinical Pharmacology and Xiangya Medical Laboratory at Central South University, and also director of Hunan Key Laboratory of Pharmacogenetics. He has been the senior visiting Scholar at Munich University in Germany from 1996-1998, and the Postdoctoral Research Fellow at Department of Toxicology and Pharmacology of Indiana University in United State of America from 2002-2004. Professor Liu has got more than 32 national and province grants and published 65 SCI papers on pharmacogenetics and pharmacogenomics published in abroad journals such as Nucleic Acids Research, Clinical Pharmacol Ther, and Clinical Cancer Research and so on. He has obtained 5 national invention patents.
Professor Liu is now focusing on the research of basic and clinical applications of Pharmacogenetics and pharmacogenomics on major diseases such as diabetes, hypertension and malignant tumor.